RxMP Therapeutics, Inc.

Private

Miami, FloridaHealthcare & Life Scienceshttps://www.rxmpt.com/

Last Round

Debt

Dec 9, 2025

Total Funding Raised

$11.3M

Company Overview

RxMP Therapeutics, Inc. is a biotechnology company that develops proprietary hemostatic therapies for the management of hemorrhage and excessive bleeding.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Defense Tech, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

hemostatic agentbiotechnologytrauma carecombat casualty carecooperative research and development agreementCRADAred blood cell microparticlesRMPhemostasisdefense techbiologicsstop bleedingsurgical bleedingblood clottingdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RxMP Therapeutics, Inc. Comps

Public and private peers based on sector, stage, and business model.

RxMP Therapeutics, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RxMP Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Dec 9, 2025
VC Round	Dec 31, 2021
Accelerator	Jul 30, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Rifat Pamukcu

Director, President & Chief Executive Officer

Executive Team

Shawna Khouri

Chief Operating Officer

Executive Team

RxMP Therapeutics, Inc. Investors

Notable investors and investment history

RxMP Therapeutics, Inc. investors
Investor	Rounds
The Wallace H. Coulter Foundation	VC Round, Debt

View all Investors

RxMP Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RxMP Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RxMP Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida

Employee Range2

Year Founded2017

Last FundingDec 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.